1. Settakis G, Molnár C, Kerényi L, Kollár J, Legemate D, Csiba L, Fülesdi B. Acetazolamide as a vasodilatory stimulus in cerebrovascular diseases and in conditions affecting the cerebral vasculature. Eur J Neurol. 2003;10(6):609-20.
2. Nishiyama T, Matsukawa T, Yokoyama T, Hanaoka K. Cerebrovascular carbon dioxide reactivity during general anesthesia: a comparison between sevoflurane and isoflurane. Anesth Analg. 1999;89:1437-1441.
3. Dagal A, Lam AM. Cerebral autoregulation and anesthesia. Curr Opin Anaesthesiol. 2009;22:547-552.
4. Mariappan R, Mehta J, Chui J, Manninen P, Venkatraghavan L. Cerebrovascular reactivity to carbon dioxide under anesthesia: a qualitative systematic review. J Neurosurg Anesthesiol. 2015;27(2):123-35.
5. Goettel N, Patet C, Rossi A, Burkhart CS, Czosnyka M, Strebel SP, Steiner LA. Monitoring of cerebral blood flow autoregulation in adults undergoing sevoflurane anesthesia: a prospective cohort study of two age groups. J Clin Monit Comput. 2016;30:255-264.
6. Sárkány P, Lengyel S, Nemes R, Orosz L, Páll D, Molnár C, Fülesdi B. Non-invasive pulse wave analysis for monitoring the cardiovascular effects of CO2 pneumoperitoneum during laparoscopic cholecystectomy--a prospective case-series study. BMC Anesthesiol. 2014;14:98.
7. Settakis G, Lengyel A, Molnár C, Bereczki D, Csiba L, Fülesdi B: Transcranial Doppler Study of the Cerebral Hemodynamic Changes During Breath-Holding and Hyperventilation Tests. J Neuroimaging 2002;12:252–258.
8. Kadoi Y, Takahashi K, Saito S, Goto F. The comparative effects of sevoflurane versus isoflurane on cerebrovascular carbon dioxide reactivity in patients with diabetes mellitus. Anesth Analg. 2006;103:168-72
9. Matta BF, Heath KJ, Tipping K, Summors AC. Direct cerebral vasodilatory effects of sevoflurane and isoflurane. Anesthesiology. 1999;91:677-680.
10. Ebert TJ, Harkin CP, Muzi M. Cardiovascular responses to sevoflurane: a review. Anesth Analg. 1995;81(6 Suppl):S11-22.
11. Fülesdi B, Limburg M, Bereczki D, Michels RP, Neuwirth G, Legemate D, Valikovics A, Csiba L. Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes. 1997;46:1840-5.
12. Páll D, Lengyel S, Komonyi E, Molnár C, Paragh G, Fülesdi B, Katona E. Impaired cerebral vasoreactivity in white coat hypertensive adolescents. Eur J Neurol. 2011;18:584-589.
13. Settakis G, Páll D, Molnár C, Bereczki D, Csiba L, Fülesdi B. Cerebrovascular reactivity in hypertensive and healthy adolescents: TCD with vasodilatory challenge. J Neuroimaging 2003;13:106-112.
14. Siró P, Molnár C, Katona É, Antek C, Kollár J, Settakis G, Fülesdi B: Carotid Intima-Media Thickness and Cerebrovascular Reactivity in Long-Term Type 1 Diabetes Mellitus J Clin Ultrasound 2009;37:451–456.
15. Molnár C, Settakis G, Sárkány P, Kálmán S, Szabó S, Fülesdi B. Effect of sevoflurane on cerebral blood flow and cerebrovascular resistance at surgical level of anaesthesia: a transcranial Doppler study. Eur J Anaesthesiol. 2007;24:179-184.
16. Gupta S, Heath K, Matta BF. Effect of incremental doses of sevoflurane on cerebral pressure autoregulation in humans. Br J Anaesth. 1997;79:469–472.
17. Summors AC, Gupta AK, Matta BF. Dynamic cerebral autoreg ulation during sevoflurane anesthesia: a comparison with isoflurane. Anesth Analg. 1999;88:341–345.
18. Sperna Weiland NH, Hermanides J, van der Ster BJP, Hollmann MW, Preckel B, Stok WJ, van Lieshout JJ, Immink RV. Sevoflurane based anaesthesia does not affect already impaired cerebral autoregulation in patients with type 2 diabetes mellitus. Br J Anaesth. 2018;121:1298-1307.